ORCID as entered in ROS

Select Publications
2019, 'Editorial: Skin blistering diseases', Frontiers in Medicine, 6, http://dx.doi.org/10.3389/fmed.2019.00060
,2019, 'Large International Validation of ABSIS and PDAI Pemphigus Severity Scores', Journal of Investigative Dermatology, 139, pp. 31 - 37, http://dx.doi.org/10.1016/j.jid.2018.04.042
,2019, 'Pemphigus vulgaris disease activity: The role of antibodies to desmogleins and their isotype', Journal of Oral Pathology and Medicine, 48, pp. 619 - 625, http://dx.doi.org/10.1111/jop.12913
,2019, 'Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.', An Bras Dermatol, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198
,2019, 'Comment les experts internationaux traitent-ils les patients atteints de pemphigoïde bulleuse à travers le monde ?', Annales de Dermatologie et de Vénéréologie, 146, pp. A62 - A62, http://dx.doi.org/10.1016/j.annder.2019.09.039
,2019, 'Corrélations entre les questionnaires de qualité de vie spécifiques aux maladies bulleuses auto-immunes ABQOL et TABQOL, et les scores de sévérité objectifs', Annales de Dermatologie et de Vénéréologie, 146, pp. A97 - A98, http://dx.doi.org/10.1016/j.annder.2019.09.100
,2019, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 5, pp. 275 - 275, http://dx.doi.org/10.1016/j.ijwd.2019.06.004
,2018, 'Probiotics for treating eczema', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD006135.pub3
,2018, 'The effect of autoimmune blistering diseases on work productivity', Journal of the European Academy of Dermatology and Venereology, 32, pp. 1959 - 1966, http://dx.doi.org/10.1111/jdv.15062
,2018, 'Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?', British Journal of Dermatology, 179, pp. 816 - 817, http://dx.doi.org/10.1111/bjd.16911
,2018, 'Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab', Clinical and Translational Allergy, 8, http://dx.doi.org/10.1186/s13601-018-0222-y
,2018, 'Pemphigoid gestationis and intravenous immunoglobulin therapy', International Journal of Women S Dermatology, 4, pp. 166 - 169, http://dx.doi.org/10.1016/j.ijwd.2018.03.007
,2018, 'The effects of autoimmune blistering diseases on work productivity: A review', International Journal of Women S Dermatology, 4, pp. 131 - 138, http://dx.doi.org/10.1016/j.ijwd.2017.11.001
,2018, 'APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aas9668
,2018, 'Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity', Indian Journal of Dermatology Venereology and Leprology, 84, pp. 431 - 436, http://dx.doi.org/10.4103/ijdvl.IJDVL_538_16
,2018, 'International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita', British Journal of Dermatology, 179, pp. 30 - 41, http://dx.doi.org/10.1111/bjd.16138
,2018, 'New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature', International Journal of Women S Dermatology, 4, pp. 102 - 108, http://dx.doi.org/10.1016/j.ijwd.2017.10.001
,2018, 'A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases', Orphanet Journal of Rare Diseases, 13, pp. 83, http://dx.doi.org/10.1186/s13023-018-0823-5
,2018, 'Osteopenia is common in mild forms of epidermolysis bullosa', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S45 - S45, http://dx.doi.org/10.1016/j.jid.2018.03.271
,2018, 'Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S10 - S10, http://dx.doi.org/10.1016/j.jid.2018.03.063
,2018, 'Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy', Otolaryngology Case Reports, 6, pp. 1 - 3, http://dx.doi.org/10.1016/j.xocr.2017.11.001
,2018, 'Psychosocial impact of inherited and autoimmune blistering diseases', International Journal of Women S Dermatology, 4, pp. 49 - 53, http://dx.doi.org/10.1016/j.ijwd.2017.11.004
,2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. 768 - 775, http://dx.doi.org/10.1111/bjd.15928
,2018, 'Use of an Investigator's Global Assessment Scale to Evaluate Disease Severity in Patients swith Epidermolysis Bullosa Simplex', SKIN The Journal of Cutaneous Medicine, 2, pp. S55 - S55, http://dx.doi.org/10.25251/skin.2.supp.55
,2018, 'Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management', Clinical Reviews in Allergy and Immunology, 54, pp. 26 - 51, http://dx.doi.org/10.1007/s12016-017-8633-4
,2018, 'A case report of the use of rituximab and the epidermolysis bullosa disease activity scoring index (EBDASI) in a patient with epidermolysis bullosa acquisita with extensive esophageal involvement', Acta Dermatovenerologica Croatica, 26, pp. 325 - 328
,2018, 'Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand', Acta Dermato Venereologica, 98, pp. 70 - 76, http://dx.doi.org/10.2340/00015555-2781
,2018, 'Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference', Frontiers in Medicine, 5, http://dx.doi.org/10.3389/fmed.2018.00306
,2018, '585 Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial', Journal of Investigative Dermatology, 138, pp. S99 - S99, http://dx.doi.org/10.1016/j.jid.2018.03.593
,2018, 'International chapters and membership of WDS are growing', International Journal of Women's Dermatology, 4, pp. 240 - 240, http://dx.doi.org/10.1016/j.ijwd.2018.10.005
,2018, 'LB1509 Anti-desmoglein levels & response to the BTK inhibitor PRN1008 in pemphigus', Journal of Investigative Dermatology, 138, pp. B7 - B7, http://dx.doi.org/10.1016/j.jid.2018.06.040
,2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. e232 - e232, http://dx.doi.org/10.1111/bjd.16385
,2018, '对过敏性皮肤炎使用全身用糖皮质激素:国际湿疹理事会共识声明', British Journal of Dermatology, 178, pp. e246 - e246, http://dx.doi.org/10.1111/bjd.16452
,2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, pp. 189, http://dx.doi.org/10.1186/s13023-017-0739-5
,2017, 'A study of the number of female editors-in-chief of dermatology journals', International Journal of Women S Dermatology, 3, pp. 185 - 188, http://dx.doi.org/10.1016/j.ijwd.2017.03.001
,2017, 'New developments in the management of congenital epidermolysis bullosa', Annales De Dermatologie Et De Venereologie, 144, pp. S6 - S7, http://dx.doi.org/10.1016/j.annder.2017.09.587
,2017, 'Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus', British Journal of Dermatology, 177, pp. 1143 - 1144, http://dx.doi.org/10.1111/bjd.15947
,2017, 'A review of 52 pedigrees with epidermolysis bullosa simplex identifying ten novel mutations in KRT5 and KRT14 in Australia', Acta Dermato Venereologica, 97, pp. 1114 - 1119, http://dx.doi.org/10.2340/00015555-2715
,2017, 'Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis', Skin Appendage Disorders, 3, pp. 179 - 181, http://dx.doi.org/10.1159/000464140
,2017, 'Quality of life in greek patients with autoimmune bullous diseases assessed with ABQOL and TABQOL indexes', Acta Dermato Venereologica, 97, pp. 1145 - 1147, http://dx.doi.org/10.2340/00015555-2737
,2017, 'The International Journal of Women's Dermatology is now listed on PubMed Central', International Journal of Women S Dermatology, 3, pp. 126, http://dx.doi.org/10.1016/j.ijwd.2017.06.003
,2017, 'Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14', British Journal of Dermatology, 177, pp. 262 - 264, http://dx.doi.org/10.1111/bjd.15053
,2017, 'Lupus profundus limited to a site of trauma: Case report and review of the literature', International Journal of Women S Dermatology, 3, pp. 117 - 120, http://dx.doi.org/10.1016/j.ijwd.2017.03.002
,2017, 'Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid', British Journal of Dermatology, 176, pp. 1428 - 1429, http://dx.doi.org/10.1111/bjd.15581
,2017, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study', BMC Cancer, 17, pp. 332, http://dx.doi.org/10.1186/s12885-017-3286-5
,2017, '2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis', Expert Review of Clinical Immunology, 13, pp. 415 - 423, http://dx.doi.org/10.1080/1744666X.2017.1304820
,2017, 'Consensus statement for the treatment of infantile haemangiomas with propranolol', Australasian Journal of Dermatology, 58, pp. 155 - 159, http://dx.doi.org/10.1111/ajd.12600
,2017, 'Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases', Journal of the American Academy of Dermatology, 76, pp. 889 - 894.e5, http://dx.doi.org/10.1016/j.jaad.2016.11.002
,2017, 'The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas', Australasian Journal of Dermatology, 58, pp. 122 - 125, http://dx.doi.org/10.1111/ajd.12431
,2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271
,